Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHBY)

32.02
Delayed Data
As of Sep 22
 -0.02 / -0.06%
Today’s Change
25.25
Today|||52-Week Range
36.82
+12.23%
Year-to-Date
Cancer Space Update: Mixed Week for Pfizer, Roche Falters
Sep 22 / Zacks.com - Paid Partner Content
Oncology Space in Focus this Week on ESMO Presentations
Sep 15 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Pfizer Files Suit against J&J, Supernus Hit by Study Update
Sep 22 / Zacks.com - Paid Partner Content
Amgen/Allergan's Avastin Biosimilar Secures FDA Approval
Sep 15 / Zacks.com - Paid Partner Content
4 Sell-Ranked Biotech Stocks with Falling Estimates to Avoid
Sep 21 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Collaborates With Halozyme for ENHANZE
Sep 15 / Zacks.com - Paid Partner Content
How is the Age-Related Macular Degeneration Space Faring Now?
Sep 21 / Zacks.com - Paid Partner Content
Roche (RHHBY) Announces Data on Respiratory Drug Esbriet
Sep 13 / Zacks.com - Paid Partner Content
Mylan Down 24% Year to Date: What's Troubling the Stock?
Sep 20 / Zacks.com - Paid Partner Content
Nektar (NKTR) Starts PROPEL Combo Study for Cancer Candidate
Sep 13 / Zacks.com - Paid Partner Content
Novartis Poised to Grow on Oncology Portfolio & Biosimilars
Sep 20 / Zacks.com - Paid Partner Content
Array's NDAs for Melanoma Combo Accepted for Review by FDA
Sep 13 / Zacks.com - Paid Partner Content
Roche (RHHBY) Announces Positive Data on Leukemia Drug
Sep 19 / Zacks.com - Paid Partner Content
Novartis' BLA for Biosimilar of Rituxan Accepted by the FDA
Sep 12 / Zacks.com - Paid Partner Content
Novartis Announces Positive Data on Urticaria Drug Xolair
Sep 18 / Zacks.com - Paid Partner Content
Roche's Ophthalmology Drug Fails to Meet Primary Endpoint
Sep 11 / Zacks.com - Paid Partner Content
Roche's (RHHBY) Tecentriq Studies Put on Partial Hold by FDA
Sep 18 / Zacks.com - Paid Partner Content